Prilosec OTC Switch Set For Early 2003 Following FDA “Approvable” Letter
Executive Summary
AstraZeneca's OTC switch for Prilosec (omeprazole) will wait until 2003 after receipt of an "approvable" letter from FDA
You may also be interested in...
Prilosec OTC
AstraZeneca/Procter & Gamble's Prilosec OTC clears FDA June 20 in 28- and 42-count package sizes to limit duration of use to 14 consecutive days and up to three courses per year. P&G plans to launch OTC omeprazole in the fall; approval follows completion of a label comprehension study as requested by FDA in an Aug. 8, 2002 "approvable" letter (1"The Pink Sheet" Aug. 26, 2002, p. 11)...
Prilosec OTC
AstraZeneca/Procter & Gamble's Prilosec OTC clears FDA June 20 in 28- and 42-count package sizes to limit duration of use to 14 consecutive days and up to three courses per year. P&G plans to launch OTC omeprazole in the fall; approval follows completion of a label comprehension study as requested by FDA in an Aug. 8, 2002 "approvable" letter (1"The Pink Sheet" Aug. 26, 2002, p. 11)...
AstraZeneca Crestor Plan: Drop 80 Mg, Submit Lower-Dose Data In Q1
AstraZeneca's updated Crestor NDA will focus on doses of 40 mg and lower following a decision not to seek approval for the 80 mg strength of the cholesterol drug